Back to Directory
Last Updated: 09/06/2026
MultiplAI Health
Cambridge
Founded 2019
RNA sequencing liquid biopsy for cardiovascular and complex disease screening
MultiplAI Health is a Cambridge biotech developing a whole-blood RNA sequencing test for early screening of cardiovascular and other complex diseases.
Its platform combines transcriptomic profiling of blood samples with a patented data transformation process and proprietary deep learning algorithms to generate precision risk assessments from a single blood draw.
The technology is designed for universal, affordable, remote screening of asymptomatic individuals, enabling proactive cardiovascular risk management.
Company Notes
AKA / Aliases
MultiplAI
Member of